metoclopramide has been researched along with Pseudohypoparathyroidism in 1 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Pseudohypoparathyroidism: A hereditary syndrome clinically similar to HYPOPARATHYROIDISM. It is characterized by HYPOCALCEMIA; HYPERPHOSPHATEMIA; and associated skeletal development impairment and caused by failure of response to PARATHYROID HORMONE rather than deficiencies. A severe form with resistance to multiple hormones is referred to as Type 1a and is associated with maternal mutant allele of the ALPHA CHAIN OF STIMULATORY G PROTEIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sowers, JR | 1 |
| Brickman, AS | 1 |
| Asp, N | 1 |
| Tuck, ML | 1 |
| Jasberg, K | 1 |
| Magnone, S | 1 |
1 other study available for metoclopramide and Pseudohypoparathyroidism
| Article | Year |
|---|---|
Altered dopaminergic modulation of prolactin and aldosterone secretion in pseudohypoparathyroidism.
Topics: Adult; Aldosterone; Dopamine Antagonists; Female; Humans; Male; Metoclopramide; Middle Aged; Posture | 1981 |